Normal neuropsychological abilities of alcoholic men in their late thirties.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 484720)

Published in Am J Psychiatry on October 01, 1979

Authors

I Grant, K Adams, R Reed

Associated clinical trials:

Neurocognitive and Neurobehavioral Mechanisms of Change Following Psychological Treatment for Alcohol Use Disorder (ABQ TREAT) | NCT03842670

Articles by these authors

(truncated to the top 100)

Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32

Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med (1979) 9.80

The role of small nuclear ribonucleoprotein particles in pre-mRNA splicing. Nature (1987) 8.28

A role for exon sequences and splice-site proximity in splice-site selection. Cell (1986) 6.41

The protein Aly links pre-messenger-RNA splicing to nuclear export in metazoans. Nature (2000) 5.57

The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 5.38

Intron sequences involved in lariat formation during pre-mRNA splicing. Cell (1985) 5.30

Splicing is required for rapid and efficient mRNA export in metazoans. Proc Natl Acad Sci U S A (1999) 4.26

SR proteins promote the first specific recognition of Pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol Cell Biol (1994) 4.25

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol (1997) 4.17

An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway. Genes Dev (1991) 3.99

Pre-mRNA splicing and mRNA export linked by direct interactions between UAP56 and Aly. Nature (2001) 3.94

The splicing factor BBP interacts specifically with the pre-mRNA branchpoint sequence UACUAAC. Cell (1997) 3.68

Helping refugee doctors. The new asylum act may make it easier to help small numbers of refugee doctors. BMJ (2000) 3.62

The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol (1990) 3.57

Limitation of medical care: an ethnographic analysis. J Clin Ethics (1993) 3.45

Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol (1997) 3.38

Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med (1982) 3.30

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. J Clin Oncol (1992) 3.17

A novel set of spliceosome-associated proteins and the essential splicing factor PSF bind stably to pre-mRNA prior to catalytic step II of the splicing reaction. EMBO J (1994) 3.17

Protein components specifically associated with prespliceosome and spliceosome complexes. Genes Dev (1992) 3.16

Detecting significant change in neuropsychological test performance: a comparison of four models. J Int Neuropsychol Soc (1999) 3.11

Evidence that sequence-independent binding of highly conserved U2 snRNP proteins upstream of the branch site is required for assembly of spliceosomal complex A. Genes Dev (1996) 3.06

Stem-cell survival and tumor control in the Lewis lung carcinoma. Cancer Res (1975) 3.04

Evaluation of the effect of WIC supplemental feeding on birth weight. J Am Diet Assoc (1982) 2.92

Analysis of the cell population kinetics of transplanted tumours of widely-differing growth rate. Br J Cancer (1966) 2.88

A functional association between the 5' and 3' splice site is established in the earliest prespliceosome complex (E) in mammals. Genes Dev (1993) 2.83

A multimodal assessment of driving performance in HIV infection. Neurology (2004) 2.81

Differential binding of heterogeneous nuclear ribonucleoproteins to mRNA precursors prior to spliceosome assembly in vitro. Mol Cell Biol (1992) 2.66

Direct control of a computer from the human central nervous system. IEEE Trans Rehabil Eng (2000) 2.65

A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site. Mol Cell Biol (1998) 2.62

The determination of low d5-phenylalanine enrichment (0.002-0.09 atom percent excess), after conversion to phenylethylamine, in relation to protein turnover studies by gas chromatography/electron ionization mass spectrometry. Rapid Commun Mass Spectrom (1992) 2.48

Test-retest reliability and practice effects of expanded Halstead-Reitan Neuropsychological Test Battery. J Int Neuropsychol Soc (1999) 2.47

Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology (2002) 2.47

Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology (2005) 2.45

Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med (1994) 2.39

Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. Arch Gen Psychiatry (1988) 2.36

Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples. Arch Clin Neuropsychol (2001) 2.35

Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. Genes Dev (1998) 2.30

Identification of proteins that interact with exon sequences, splice sites, and the branchpoint sequence during each stage of spliceosome assembly. Mol Cell Biol (1996) 2.29

Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet (2000) 2.29

Functional association of U2 snRNP with the ATP-independent spliceosomal complex E. Mol Cell (2000) 2.27

Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens. Clin Infect Dis (1993) 2.07

Resolution of the mammalian E complex and the ATP-dependent spliceosomal complexes on native agarose mini-gels. RNA (1999) 2.06

Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med (1982) 2.06

Introduction to background papers for the suggested changes to DSM-IV: cognitive disorders. J Neuropsychiatry Clin Neurosci (1992) 2.04

Direct interactions between pre-mRNA and six U2 small nuclear ribonucleoproteins during spliceosome assembly. Mol Cell Biol (1994) 2.03

Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia (2000) 2.02

Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. J Clin Oncol (1992) 2.00

Stress, vulnerability and adult alcohol relapse. J Stud Alcohol (1995) 2.00

Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol (1997) 2.00

A factor analysis of the Klein sexual orientation grid in two disparate samples. Arch Sex Behav (1993) 1.98

A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol (1988) 1.96

Identification of both shared and distinct proteins in the major and minor spliceosomes. Science (1999) 1.96

Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology (2000) 1.91

Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol (1999) 1.89

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke (1992) 1.89

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology (2000) 1.88

The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol (2001) 1.86

Evidence that U5 snRNP recognizes the 3' splice site for catalytic step II in mammals. EMBO J (1997) 1.85

A two-step mechanism for 5' and 3' splice-site pairing. Nature (1995) 1.85

An X-ray and electron microscope study of tropomyosin. Biochem J (1948) 1.85

Identification of a functional mammalian spliceosome containing unspliced pre-mRNA. Proc Natl Acad Sci U S A (1988) 1.85

Episodic and semantic memory: a comparison of amnesic and demented patients. J Clin Exp Neuropsychol (1987) 1.85

Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits. Antimicrob Agents Chemother (1989) 1.78

PEAPS-Q: a questionnaire to measure the psychosocial effects of having an abnormal pap smear. Psychosocial Effects of Abnormal Pap Smears Questionnaire. J Clin Epidemiol (1995) 1.77

Ganglioside storage diseases. Fed Proc (1971) 1.76

The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group. J Int Neuropsychol Soc (1999) 1.75

Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol (2009) 1.75

Characterization of a protein complex containing spliceosomal proteins SAPs 49, 130, 145, and 155. Mol Cell Biol (1999) 1.73

Getting nutrition education into medical schools: a computer-based approach. Am J Clin Nutr (2000) 1.73

Correspondence between a mammalian spliceosome component and an essential yeast splicing factor. Science (1993) 1.71

Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain (1999) 1.71

Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol Clin Exp Res (1991) 1.71

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol (2005) 1.68

Longitudinal analysis of multiple indicators of health decline among spousal caregivers. Ann Behav Med (1997) 1.68

Association of guide RNA binding protein gBP21 with active RNA editing complexes in Trypanosoma brucei. Mol Cell Biol (1998) 1.66

Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol (1998) 1.66

Analysis of covariance as a remedy for demographic mismatch of research subject groups: some sobering simulations. J Clin Exp Neuropsychol (1985) 1.66

The Paced Auditory Serial Addition Task (PASAT): norms for age, education, and ethnicity. Assessment (1998) 1.65

WW domain-mediated interactions reveal a spliceosome-associated protein that binds a third class of proline-rich motif: the proline glycine and methionine-rich motif. Proc Natl Acad Sci U S A (1998) 1.64

Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol (2012) 1.60

An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing. Mol Cell Biol (2001) 1.57

The prespliceosome components SAP 49 and SAP 145 interact in a complex implicated in tethering U2 snRNP to the branch site. Genes Dev (1994) 1.57

Frequency of abdominal wall hernias: is classical teaching out of date? JRSM Short Rep (2011) 1.57

Human homologs of yeast prp16 and prp17 reveal conservation of the mechanism for catalytic step II of pre-mRNA splicing. EMBO J (1998) 1.56

Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med (1983) 1.55

Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc (2011) 1.53

Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells. Mol Cell Biol (1998) 1.52

Demographically corrected norms for the Brief Visuospatial Memory Test-revised and Hopkins Verbal Learning Test-revised in monolingual Spanish speakers from the U.S.-Mexico border region. Arch Clin Neuropsychol (2007) 1.50

Neuropsychological function in mild sleep-disordered breathing. Sleep (1997) 1.48

Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease. Ann Intern Med (1982) 1.48

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology (2012) 1.48

Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers. J Psychosom Res (1999) 1.47

Reduced mortality risk in alcoholics who achieve long-term abstinence. JAMA (1992) 1.46

Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Arch Neurol (1993) 1.45

Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1992) 1.44

Natural history of neuropsychiatric manifestations of HIV disease. Psychiatr Clin North Am (1994) 1.43

In situ and small invasive breast cancer register in Victoria, 1988 to 1992: tumour characteristics and patient management. ANZ J Surg (2001) 1.42